There have been no published studies evaluating the efficacy and safety of weekly liposomal amphotericin B as secondary prophylaxis in leukemic patients with invasive fungal infections (IFIs). We found in a retrospective review of our experience with 14 such patients admitted from 20032009 that the use of this approach was associated with frequent relapse of IFIs (36%) and kidney injury (36%)
L. Cahuayme-Zuniga, R. E. Lewis, V. E. Mulanovich, D. P. Kontoyiannis (2012). Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies. MEDICAL MYCOLOGY, 50, 543-548 [10.3109/13693786.2011.631152].
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies
LEWIS, RUSSEL EDWARD;
2012
Abstract
There have been no published studies evaluating the efficacy and safety of weekly liposomal amphotericin B as secondary prophylaxis in leukemic patients with invasive fungal infections (IFIs). We found in a retrospective review of our experience with 14 such patients admitted from 20032009 that the use of this approach was associated with frequent relapse of IFIs (36%) and kidney injury (36%)I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
